Antibody-based drug discovery at the speed of light

icons/content-types/white paper white paper

The combination of the PentaMice® platform and single B cell screening with the Berkeley Lights Beacon® Optofluidic system increases speed to market for monoclonal antibody therapeutics.

The Beacon® system is an innovative package using the technology of light, nanofluidics and refined AI algorithms to identify and orchestrate the movement of single B cells into a grid of NanoPen™ chambers for screening.

Download our white paper for insights on:

  • First-to-Human antibody therapeutics
  • Immunization — PentaMice® platform for antibody generation
  • Single B cell screening with the Beacon® system
  • Sequence Identification
  • Custom Bioinformatics
  • Case Study: Discovery of diverse monoclonal antibodies that bind SARS-CoV-2 Delta and Omicron spike proteins
    Gene-to-Protein Strategies

Download the White Paper

Ready to move from idea to impact?

Whether you have a question for our team or an opportunity you’re eager to pursue, one of our experts can help you get started.

Contact Us